logo
How was Rome's most iconic fish sauce made? Scientists decode 2,000-year-old DNA to reconstruct garum

How was Rome's most iconic fish sauce made? Scientists decode 2,000-year-old DNA to reconstruct garum

Time of India3 days ago
A genetic window into ancient Roman cuisine
Live Events
The marine economy
The Archaeology and Ecology
The garum recipe
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
Archaeologists have identified the fish used to make ' garum ,' Rome's favorite sauce, not by sight but by sequencing ancient DNA from fragmented bones found in a fish-salting vat in northwestern Spain. The breakthrough reveals that European sardines were a primary ingredient in the iconic fermented condiment.This new genetic evidence could open the door to knowing what Romans ate 2000 years ago and how they processed marine resources on a commercial scale.This discovery, led by a multidisciplinary team of archaeologists and geneticists published in Antiquity, confirms long-standing theories about garum's recipe.The remains were recovered from a cetaria, a coastal fish-processing plant, where garum was produced by fermenting small fish in salt.Researchers used a novel method of overlapping fragmented DNA sequences and aligning them with complete fish genomes to identify species that were previously unrecognizable using visual methods.'Fish bones are a frequent find in the archaeological record of the Roman period, yet their use in archaeogenetic studies is residual,' said Dr. Paula F. Campos from CIIMAR, Universidade do Porto.'Despite enduring conditions that promote DNA degradation, the methods we outline allow for the identification of species from these processed bones.'The study confirmed the use of sardines in ancient garum production and revealed striking genetic continuity with modern sardines found in the same region today.This continuity challenges assumptions about sardine populations' mobility and genetic variability over two millennia.Garum was not merely a condiment but central to Roman cuisine and commerce.Its long shelf life and savory umami flavor made it a staple across Roman kitchens and a tradable commodity throughout the empire, especially from the coasts of Hispania (modern Spain and Portugal) and Tingitana (in present-day Morocco).While sardines dominated this site's production, remains from other garum production sites indicate that herring, whiting, mackerel, and anchovy were also used, pointing to a more diverse marine resource base.The team's success opens doors for future archaeogenetic investigations into other ancient food production methods. Importantly, it also creates a new avenue for examining how ancient societies managed marine resources and how such exploitation has affected fish populations over time.'This might help identify with more precision some regional variations in the main ingredients of the ancient fish sauces and pastes,' said Annalisa Marzano of the University of Bologna, who was not involved in the study.By reconstructing ancient diets and trade networks, such research could inform current marineCampos and her team are now broadening their scope. 'We are expanding the sampling locations to see if the results are consistent across the entire Roman Empire ,' she noted.Archaeogenomics may soon unravel more connections between ancient food culture, ecology, and global trade patterns.This study also supported the known technique of making garum in ancient Rome.Garum was made by layering small fish, often sardines or anchovies, with large amounts of salt in clay vats at coastal processing centers known as cercariae.The mixture was left to ferment naturally under the sun for weeks or months. As the fish broke down, a pungent, amber-colored liquid rose to the top.This liquid, strained and bottled, became garum, a prized condiment known for its rich umami flavor. The process was labor-intensive but sustainable, using every part of the fish and requiring no added preservatives thanks to the salt.Today, many home cooks and culinary historians are reviving the ancient recipe using modern tools and ingredients.In home kitchens, small batches of garum are often made using glass jars or food-safe containers, mixing fish scraps (like heads and bones) with salt and sometimes koji, a Japanese fermentation agent, to accelerate the breakdown.Fermentation typically takes a few weeks at room temperature, and while the process still yields a strong aroma, the end product is surprisingly mellow and versatile.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Godavari Biorefineries secures EU patent for anti-cancer molecule
Godavari Biorefineries secures EU patent for anti-cancer molecule

Fibre2Fashion

time14 hours ago

  • Fibre2Fashion

Godavari Biorefineries secures EU patent for anti-cancer molecule

Godavari Biorefineries Limited (BSE: 544279 | NSE: GODAVARIB) announced that its European patent for a novel anti-cancer molecule has been validated in Spain, the United Kingdom, and as a Unitary Patent covering multiple EU member states. This milestone underscores the company's growing presence in high-impact scientific innovation, led by its dedicated Anti-Cancer Research Segment. Godavari Biorefineries' anti-cancer molecule patent has been validated in Spain, the UK, and as a Unitary Patent in the EU. Now in Phase 1a trials, the molecule shows promise against various cancers. This milestone boosts GBL's scientific innovation presence, led by Sathgen Therapeutics, and supports its broader push into biotech alongside its core bio-based businesses. The patented molecule has demonstrated efficacy against both cancer cells and cancer stem cells, marking a promising advance toward more targeted and effective cancer therapies. It has shown potential in the treatment of various cancers, including breast and prostate cancer, with encouraging efficacy and safety profiles in preclinical animal studies. The molecule is currently in Phase 1a clinical trials to assess safety in human patients with advanced solid tumors as well as in healthy volunteers. "This patent validation marks a significant milestone in our journey toward advancing original, high-quality scientific research," said Sangeeta Srivastava, Executive Director, Godavari Biorefineries Limited. "It reflects the dedication of our teams and our aspiration to contribute meaningfully to global knowledge and innovation." Godavari Biorefineries has established a global presence, exporting to over 20 countries and maintaining strong linkages with international research and development networks. The company's clinical-stage biotech division, Sathgen Therapeutics, is at the forefront of advancing novel cancer and antiviral therapies. With a lead molecule undergoing clinical trials and global patent protection, GBL is deepening its investment in translational research that addresses some of the world's most urgent health challenges. This development highlights GBL's growing diversification into advanced scientific domains, complementing its leadership in ethanol, bio-based chemicals, and renewable materials produced from agricultural feedstocks. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. ALCHEMPro News Desk (HU)

Andhra govt unveils Amaravati Quantum Valley plan, eyes USD 1 bn investment by 2029
Andhra govt unveils Amaravati Quantum Valley plan, eyes USD 1 bn investment by 2029

Time of India

time16 hours ago

  • Time of India

Andhra govt unveils Amaravati Quantum Valley plan, eyes USD 1 bn investment by 2029

Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Amaravati, The Andhra Pradesh government on Monday approved the Amaravati Quantum Valley Declaration, which will guide the state's efforts to advance quantum technologies and build a vibrant innovation ecosystem, including attracting USD 1 billion in investments by January 1, declaration follows deliberations held during the recent Quantum Valley Workshop in Vijayawada."The Government hereby approves the Amaravati Quantum Valley Declaration. This shall serve as a guiding framework for the state's efforts to advance quantum technologies and nurture a vibrant innovation ecosystem," said Bhaskar Katamneni, Secretary to the Government, in a declaration outlines shared commitments, a long-term vision, and strategic priorities for quantum research , innovation, talent development, infrastructure creation, and international reflects Andhra Pradesh's ambition to transform Amaravati into a globally competitive hub for quantum science and workshop hosted discussions on quantum computing , algorithms, hardware, quantum sensing and communication, quantum materials, capacity building, standardization, and a startup ecosystem for part of joint commitments from global partners, scholars, startups, industry leaders, and other stakeholders, the Amaravati Quantum Valley (AQV) will establish a Living Lab includes setting up QChipIN , India's largest open quantum testbed, within a year. It will integrate quantum computers, QKD fibre links, and deployable sensor platforms to support pilot projects across health-tech, Banking, Financial Services, and Insurance (BFSI), logistics, defence, and space will provide end-to-end access to quantum hardware, algorithms, tools, and expert support, housed within a dedicated tech park in collaboration with industry and academia to accelerate domestic R& January 1, 2026, IBM is expected to install its Quantum System Two at AQV, with a target of testing 100 quantum algorithms by the same time. By January 1, 2027, three quantum computers based on different qubit technologies-including superconducting circuits, trapped ions, photonic qubits, and neutral atoms-are targets include testing over 1,000 quantum algorithms annually by January 1, 2028, and achieving 1,000 effective qubits of total quantum capacity by January 1, boost domestic production, AQV will anchor the indigenous supply chain for qubit platforms, cryo-electronics, photonic packages, quantum chips, quantum dots, readout hardware like single-photon detectors, and control systems, to reach Rs 5,000 crore in annual exports by addition to talent development, AQV will spearhead the creation of a National Startup Forum with milestone-based VC funding and mentorship.A dedicated Rs 1,000 crore Quantum Fund and access to Living Lab infrastructure will support at least 20 quantum hardware and security startups in the next year and 100 by 2030, said the declaration. Startups will also benefit from regulatory quantum valley aims to attract a minimum of USD 500 million in investments by January 1, 2027, and USD 1 billion by January 1, 2029, focusing on quantum computing, chips, sensing, and Pradesh will also establish a Global Quantum Collaboration Council (GQCC) in Amaravati to align international standards, foster joint R&D, and promote trusted supply chains.A multi-stakeholder Amaravati Quantum Valley Mission Board will oversee governance, with working groups identifying use cases for quantum computing across in 2026, Amaravati will host an annual World Quantum Expo, with the goal of becoming India's quantum capital and a global hub for deep tech innovation by 2035.

Godavari Biorefineries' anti-cancer patent now validated in Spain and the UK
Godavari Biorefineries' anti-cancer patent now validated in Spain and the UK

Business Standard

time18 hours ago

  • Business Standard

Godavari Biorefineries' anti-cancer patent now validated in Spain and the UK

And as Unitary Patent covering multiple EU member states Godavari Biorefineries announced that its European patent for a novel anti-cancer molecule has been validated in Spain, the United Kingdom, and as a Unitary Patent covering multiple EU member states. This milestone underscores the company's growing presence in high-impact scientific innovation, led by its dedicated Anti-Cancer Research Segment. The patented molecule has demonstrated efficacy against both cancer cells and cancer stem cells, marking a promising advance toward more targeted and effective cancer therapies. It has shown potential in the treatment of various cancers, including breast and prostate cancer, with encouraging efficacy and safety profiles in preclinical animal studies. The molecule is currently in Phase 1a clinical trials to assess safety in human patients with advanced solid tumors as well as in healthy volunteers.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store